Home Telomir Pharmaceuticals

Telomir Pharmaceuticals

In operation
IPO
Small Molecule Drug Developer

Basic Information

Telomir Pharmaceuticals has developed a novel therapeutic approach that interferes with enzyme function by binding to key metals, restoring cellular metal homeostasis for iron, copper, and zinc, and eliminating the root causes of cancer development and growth. Telomir 1 is a small molecule drug designed to regulate telomere length and genomic stability.
Telomir Pharmaceuticals, Inc.
Baltimore,Maryland,United States of America
less than 15 people
January 01, 2022
info@Telomirpharma.com